Back to Search Start Over

Predictors of disability worsening in clinically isolated syndrome.

Authors :
Jokubaitis, Vilija G.
Spelman, Tim
Kalincik, Tomas
Izquierdo, Guillermo
Grand'Maison, François
Duquette, Pierre
Girard, Marc
Lugaresi, Alessandra
Grammond, Pierre
Hupperts, Raymond
Cabrera‐Gomez, José
Oreja‐Guevara, Celia
Boz, Cavit
Giuliani, Giorgio
Fernández‐Bolaños, Ricardo
Iuliano, Gerardo
Lechner‐Scott, Jeannette
Verheul, Freek
Pesch, Vincent
Petkovska‐Boskova, Tatjana
Source :
Annals of Clinical & Translational Neurology; May2015, Vol. 2 Issue 5, p479-491, 13p
Publication Year :
2015

Abstract

Objective To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predictors of time to 3 or 12-month confirmed disability worsening in clinically isolated syndrome (CIS) and early multiple sclerosis (MS). Methods We utilized the MSBase Incident Study ( MSBasis), a prospective cohort study of outcome after CIS. Predictors of time to first 3 and 12-month confirmed expanded disability status scale worsening were analyzed using Cox proportional hazards regression. Results About 1989 patients were analyzed, the largest seen-from-onset cohort reported to-date. A total of 391 patients had a first 3-month confirmed disability worsening event, of which 307 were sustained for 12 months. Older age at CIS onset (adjusted hazard ratio: aHR 1.17, 95% 1.06, 1.30), pyramidal ( aHR 1.45, 95% CI 1.13, 1.89) and ambulation ( HR 1.60, 95% CI 1.09, 2.34) system dysfunction, annualized relapse rate ( aHR 1.20, 95% CI 1.18, 1.22), and lower proportion of observation time on treatment were associated with 3-month confirmed worsening. Predictors of time to 12-month sustained worsening included pyramidal system dysfunction (Hazard ratio: aHR 1.38, 95% CI 1.05, 1.83), and older age at CIS onset ( aHR 1.17, 95% CI 1.04, 1.31). Greater proportion of follow-up time exposed to treatment was associated with greater reductions in the rate of worsening. Interpretation This study provides class IV evidence for a strong protective effect of disease-modifying treatment to reduce disability worsening events in patients with CIS and early MS, and confirms age and pyramidal dysfunction at onset as risk factors. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
23289503
Volume :
2
Issue :
5
Database :
Complementary Index
Journal :
Annals of Clinical & Translational Neurology
Publication Type :
Academic Journal
Accession number :
102644224
Full Text :
https://doi.org/10.1002/acn3.187